Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

820 public trials 196 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Active, Not Recruiting

DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer

NCT06077500

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • AZ Groeninge Kortrijk, Belgium
View all 21 locations
View Trial Details
Active, Not Recruiting

Study of AZD2811 + Durvalumab in ES-SCLC

NCT04745689

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Research Site Grand Rapids, Michigan, United States
  • Research Site Bydgoszcz, Poland
  • Research Site Olsztyn, Poland
  • Research Site Poznan, Poland
View Trial Details
Active, Not Recruiting

Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs

NCT03896503

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Carcinoma, +13 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer

NCT05091567

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital Marietta, Georgia, United States
  • Illinois Cancer Care Peoria, Illinois, United States
  • New England Cancer Specialists Scarborough, Maine, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 95 locations
View Trial Details
Active, Not Recruiting

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT06257264

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +55 more
Locations
  • Hoag Memorial Presbyterian Newport Beach, California, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Titan Health Partners Llc Dba Astera Cancer Care East Brunswick, New Jersey, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

NCT01638546

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

NCT02498613

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Diego Medical Center - Hillcrest San Diego, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
View all 16 locations
View Trial Details

Related conditions